Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Apply
Ficlatuzumab & Cetuximab
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step